Clinical trials: Pelvic Bleeding

Breakthrough Bleeding, Breakthrough Spotting

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

• Completed
• Age: 18 to 45 years
• Pill or oral medicine

The purpose of this research study is to evaluate the best way to manage breakthrough spotting and bleeding during an extended use regimen of NuvaRing®.

Trial name

NCT00475553

Testing

remove ring if bleeding or spotting occurs more than 5 days, If bleeding does not remove ring

Where

United States

Volunteers

75 people, healthy volunteers welcome

Sponsor

Scott and White Hospital & Clinic